(90 days)
The Infinit® Vision System is indicated for emulsification, separation, and removal of cataracts, the removal of residual cortical material and lens epithelial cells, vitreous aspiration and cutting associated with anterior vitrectomy, bipolar coagulation, and intra-ocular lens injection. The AutoSert™ IOL Injector Handpiece is intended to deliver qualified AcrySof® intraocular lenses into the eye following cataract removal.
The following system modalities additionally support the described indications:
- Ultrasound with UltraChopper Tip achieves the functionality of cataract separation.
- AquaLase achieves the functionality for removal of residual cortical material and lens epithelial cells
- The AutoSert ™ IOL Injector Handpiece achieves the functionality of injection of intraocular lenses. The AutoSert™ is indicated for use with ACRYSOF lenses SN60WF and SN6AD1, as well as approved AcrySof lenses that are specifically indicated for use with this inserter, as indicated in the approved labeling of those lenses.
The Infinit® Vision System is an enhanced version of the Infinit® Vision System with OZil® IP (K082845) that is modular in design and incorporates the Power Watch feature, along with the Alcon UltraChopper Tip, the AquaLase Capsule Wash Tip, the AutoSert™ IOL Injector, and its associated software.
This is a 510(k) premarket notification for the Infiniti® Vision System. As such, it reports on non-clinical testing to demonstrate substantial equivalence to previously cleared predicate devices, rather than a clinical study with acceptance criteria for a new device's performance.
Therefore, many of the requested categories regarding clinical study design and performance metrics (e.g., sample size for test set, number of experts for ground truth, MRMC study, standalone performance, training set details) are not applicable in the context of this 510(k) summary.
Here's a breakdown of the relevant information provided:
1. Table of Acceptance Criteria and Reported Device Performance:
Since this is a non-clinical submission focused on substantial equivalence to existing predicate devices, the "acceptance criteria" are compliance with established medical device standards and demonstrating that the new features do not negatively impact safety or effectiveness. The "reported device performance" is essentially that the device meets these standards and maintains equivalent functionality.
| Acceptance Criteria Category | Reported Device Performance |
|---|---|
| Safety and Functional Standards | Device complies with applicable requirements of numerous standards, including: - ISO 11135-1:2007 (Sterilization) - BS EN ISO 11979-3:2006 (Intraocular Lenses Mechanical Properties) - EN ISO 14971:2007 (Risk Management) - IEC 60601-1 (General Safety of Medical Electrical Equipment) - IEC 60601 series (Collateral and Particular Requirements for Medical Electrical Equipment and Ophthalmic Devices)- BioCompatibility Standards (ISO 10993 series) |
| Material Biocompatibility | Biocompatibility evaluations of patient fluid path materials performed to ISO 10993 standards (Parts 1, 5, 10, 11, 12). |
| Sterilization Efficacy | EtO sterilization process for sterile accessories validated per ISO 11135-1:2007. |
| Reprocessing Instructions | Validated reprocessing instructions (cleaning, sterilization, re-use) provided for reusable handpieces. |
| Manufacturing and Design Control | Developed and manufactured in compliance with 21 CFR 820 (Quality System Regulation) and ISO 14971:2007 (Risk Management). |
| Functional Equivalence | Non-clinical testing demonstrated that the functional requirements have been met and that the modified device is equivalent to the predicate device. Technological characteristics affecting clinical performance are similar to predicate devices. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
- Not Applicable. This 510(k) relies on non-clinical testing against established standards and comparison to predicate devices, not on a clinical test set with human patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
- Not Applicable. Ground truth, in the sense of expert consensus on patient data, is not part of this type of submission. The "ground truth" for non-clinical testing relates to objective measurements against standard specifications.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not Applicable. No clinical test set requiring adjudication of findings is described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not Applicable. This device is a surgical system, not an AI-assisted diagnostic tool for human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not Applicable. This is a hardware/software medical device used by a human surgeon, not a standalone algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- For non-clinical testing, the "ground truth" is defined by engineering specifications, recognized national and international standards (e.g., ISO, IEC), and established predicate device performance. For biocompatibility, it's the results of standardized biological tests. For sterilization, it's the validation against the specified sterilization cycle.
8. The sample size for the training set:
- Not Applicable. This is a medical device, not a machine learning algorithm that requires a "training set" in the conventional sense. The development likely involved iterative design and testing, but not a dataset for training an AI model.
9. How the ground truth for the training set was established:
- Not Applicable. As above, no training set for an AI model is described.
{0}------------------------------------------------
NOV 2 1 2011
PREMARKET NOTIFICATION 510(k) SUMMARY
The submitter of the 510(k) is:
Martin A. Kaufman Director. Regulatory Affairs Alcon Research, Ltd. 18500 Alton Parkway Irvine, CA 92618 Phone: (949) 753-6250 Fax: (949) 753-6237
Device Subject to this 510(k):
Trade Name: Common Name: Classification Name: Infiniti® Vision System Phacofragmentation System Phacofragmentation System (per 21 CFR 886.4670)
Predicate Devices:
The legally marketed devices(s) to which we are claiming equivalence to are:
| 510(k) Number | Device |
|---|---|
| K021566 | Infiniti® Vision System |
| K082845 | Infiniti® Vision System with OZil® IP |
| K091777 | Alcon UltraChopper Tip |
| K093210 | AquaLase Capsule Wash Tip |
| K063155 | Monarch III IOL Delivery System |
Device Description
The Infinit® Vision System is an enhanced version of the Infinit® Vision System with OZil® IP (K082845) that is modular in design and incorporates the Power Watch feature, along with the Alcon UltraChopper Tip, the AquaLase Capsule Wash Tip, the AutoSert™ IOL Injector, and its associated software.
{1}------------------------------------------------
Indications for Use:
The Infinity Vision System is indicated for emulsification, separation, and removal of cataracts, the removal of residual cortical material and lens epithelial cells, vitreous aspiration and cutting associated with anterior vitrectomy, bipolar coagulation, and intraocular lens injection. The AutoSert™ IOL Injector Handpiece is intended to deliver qualified AcrySof® intraocular lenses into the eye following cataract removal.
The following system modalities additionally support the described indications:
- Ultrasound with UltraChopper Tip achieves the functionality of cataract separation. -
- AquaLase achieves the functionality for removal of residual cortical material and lens epithelial cells
- The AutoSert™ IOL Iniector Handpiece achieves the functionality of injection of । intraocular lenses. The AutoSert™ is indicated for use with ACRYSOF lenses SN60WF and SN6AD1, as well as approved Acrysof lenses that are specifically indicated for use with this inserter, as indicated in the approved labeling of those lenses.
Brief Summary of Nonclinical test and Results:
Safety tests of the Infinity Vision System have demonstrated its compliance with applicable requirements of the following standards:
| Standard # | Title |
|---|---|
| 11135-1:2007ISO | Sterilization of health care products - Ethylene oxide - Requirementsfor development, validation, and routine control of a sterilizationprocess for medical devices. |
| 11979-3:2006BS EN ISO | Ophthalmic implants - Intraocular Lenses - Part 3: Mechanicalproperties and test methods |
| 14971:2007EN ISO | Medical Devices: Application of Risk Management to Medical Devices |
| IEC 60601-1:1988, A1:1991,A2:1995 | Medical Electrical Equipment - Part 1: General requirements for safety |
| IEC 60601-1-1:2000 | Medical electrical equipment. Part 1-1: General requirement for safety -Collateral standard: Safety requirements for medical electricalsystems |
| EN 60601-1-2:2004 | Medical electrical equipment - Part 1: General requirements for safety 2.Collateral Standard: Electromagnetic compatibility - Requirements andtests |
| IEC 60601-1-4:2000 | Medical electrical equipment - Part 1: General requirements for safety -4. Collateral standard: Programmable electrical medical systems. |
| IEC 60601-1-6:2006 | Medical electrical equipment - Part 1-6: General requirements for safety -Collateral standard: Usability. |
| IEC 60601-2-2:2006 | Medical electrical equipment - Part 2: Particular requirements for thesafety of high frequency surgical equipment. |
| IEC 80601-2-58:2008 | Medical electrical equipment -- Part 2-58: Particular requirements forbasic safety and essential performance of lens removal devices andvitrectomy devices for ophthalmic surgery |
{2}------------------------------------------------
Biocompatibility evaluations of materials coming in contact with the patient fluid path have been performed to the following standards:
| Standard # | Title |
|---|---|
| ISO 10993-1:2009 | Biological Evaluation of Medical Devices -- Part 1: Evaluation andTesting within a Risk management Process |
| ISO 10993-5:2009 | Biological Evaluation of medical devices -- Part 5: Tests for In Vitrocytotoxicity |
| ISO 10993-10:2002/A1:2006 | Biological Evaluation of Medical Devices -- Part 10: Tests for irritationand delayed-type hypersensitivity |
| ISO 10993-11:2006 | Biological Evaluation of Medical Devices -- Part 11: Tests for systemictoxicity |
| ISO 10993-12:2007 | Biological Evaluation of Medical Devices --Part 12: Sample Preparationand Reference Materials |
Many Infiniti® accessories are provided sterile and are intended for single use only. These products are EtO sterilized and the process has been validated per ISO 11135-1:2007: Medical Devices - Validation and Routine Control of Ethylene Oxide Sterilization. Reusable handpieces are provided non-sterile. Validated reprocessing instructions for cleaning, sterilization, and re-use of the handpieces are provided in the Directions for Use of the product.
Technological characteristics affecting clinical performance are similar to that of predicate devices previously listed. The Infiniti® Vision System has been developed and will be manufactured in compliance with 21 CFR 820 and ISO 14971:2007. Non-clinical testing noted above has demonstrated that the functional requirements have been met and that the modified device is equivalent to the predicate device.
Accessories Provided with the System (subject to change)
| Configurations of tips and sleeves currently used with the Irrigation/Aspiration Handpiece.Description |
|---|
| ASSY, SHIP, INTREPID POLYMER I/A TIP, STRAIGHT |
| ASSY, SHIP, INTREPID POLYMER I/A TIP, ANGLED |
| ASSY, SHIP, INTREPID POLYMER I/A TIP, CURVED |
| I/A Tip 0.5 mm |
| I/A Tip 0.2 mm |
| I/A Tip 0.3 mm Small Bore |
| I/A Tip 0.3 mm Small Bore Mod |
| I/A Tip 0.3 mm Bent |
| I/A Tip 0.3 mm Bent & Sand Blast |
| I/A Tip .033 OD, .3mm, Intrepid |
{3}------------------------------------------------
| Configurations of tips and sleeves currently used with the Irrigation/Aspiration Handpiece. | Description |
|---|---|
| I/A Tip .033 OD, .3mm Bent, Intrepid | |
| Silicone I/A Tip, Bent | |
| Silicone I/A Tip, Straight | |
| Ultraflow Tool/O-rings | |
| Ultraflow IA Handpiece Comp | |
| Ultraflow IA Handpiece Only | |
| Ultraflow IA Tip STR | |
| Ultraflow IA Tip CRVD | |
| Ultraflow IA 45 | |
| Ultraflow IA 90 | |
| Ultraflow IA 120 | |
| Ultraflow CNL STTL | |
| Ultraflow Luer | |
| Straight Tip, 3 mm | |
| Ultraflow Tip Protector, Standalone | |
| 45° Bent Tip, .3 mm | |
| 90° Bent Tip, .3mm | |
| Irrigation Only Luer | |
| Curved Tip, .3mm | |
| Threaded Tip - STTL | |
| Ultraflow I/A Box | |
| Replacement O-ring |
Configurations of Paks currently used with the Infiniti Vision System.
| Description |
|---|
| Ultrasound FMS, Basic |
| Ultrasound FMS, Tipless, 0.9mm |
| Ultrasound FMS, Tipless, 1.1mm |
| Ultrasound FMS, Tipless, 0.9mm HIS |
| Ultrasound FMS, Tipless, 1.1mm HIS |
| Ultrasound FMS, 30° Round, 0.9 mm ABS |
| Ultrasound FMS, 45° Round, 0.9 mm ABS |
| Ultrasound FMS, 30° Kelman, 0.9 mm ABS |
| Ultrasound FMS, 45° Kelman, 0.9 mm ABS |
| Ultrasound FMS, 30° Round, 1.1 mm ABS |
| Ultrasound FMS, 45° Round, 1.1 mm ABS |
| Ultrasound FMS, 30° Kelman, 1.1 mm ABS |
| Ultrasound FMS, 45° Kelman, 1.1 mm ABS |
| Ultrasound FMS, 30° Round, 0.9 mm MicroTip Flared ABS |
| Ultrasound FMS, 45° Round, 0.9 mm MicroTip Flared ABS |
| Ultrasound FMS, 30° Kelman, 0.9 mm MicroTip Flared ABS |
| Ultrasound FMS, 45° Kelman, 0.9 mm MicroTip Flared ABS |
| Description |
| Ultrasound FMS, 30° Round, 1.1 mm Flared ABS |
| Ultrasound FMS, 45° Round, 1.1 mm Flared ABS |
| Ultrasound FMS, 30° Kelman, 1.1 mm Flared ABS |
| Ultrasound FMS, 45° Kelman, 1.1 mm Flared ABS |
| Ultrasound FMS, 30° Round, 0.9 mm Mackool |
| Ultrasound FMS, 45° Round, 0.9 mm Mackool |
| Ultrasound FMS, 30° Kelman, 0.9 mm Mackool |
| Ultrasound FMS, 45° Kelman, 0.9 mm Mackool |
| Ultrasound FMS, 30° Round, 1.1 mm Mackool Flared ABS |
| Ultrasound FMS, 45° Round, 1.1 mm Mackool Flared ABS |
| Ultrasound FMS, 30° Kelman, 1.1 mm Mackool Flared ABS |
| Ultrasound FMS, 45° Kelman, 1.1 mm Mackool Flared ABS |
| Ultrasound FMS, 30° Round, 0.9 mm Tapered ABS |
| Ultrasound FMS, 45° Round, 0.9 mm Tapered ABS |
| Ultrasound FMS, 30° Kelman, 0.9 mm Tapered ABS |
| Ultrasound FMS, 45° Kelman, 0.9 mm Tapered ABS |
| Ultrasound FMS, Tipless, 0.9 Ultra |
| Ultrasound FMS, 30° Kelman, 0.9 mm Mini Flared ABS, Ultra |
| Ultrasound FMS, 45° Kelman, 0.9 mm Mini Flared ABS, Ultra |
| Ultrasound FMS, 30° OZil 12, 0.9 mm Mini Flared ABS, Ultra |
| Ultrasound FMS, 45° OZil 12, 0.9 mm Mini Flared ABS, Ultra |
| Ultrasound FMS, 30° Kelman, 0.9 mm Mini Flared ABS |
| Ultrasound FMS, 45° Kelman, 0.9 mm Mini Flared ABS |
| Ultrasound FMS, 30° OZil 12, 0.9 mm Mini Flared ABS |
| Ultrasound FMS, 45° OZil 12, 0.9 mm Mini Flared ABS |
| Ultrasound FMS, Tipless, 0.9mm J |
| Ultrasound FMS, Tipless, 1.1mm J |
| Ultrasound FMS, Tipless, 0.9mm HIS J |
| Ultrasound FMS, Tipless, 1.1mm HIS J |
| Ultrasound FMS, Tipless, 0.9 Ultra J |
| Ultrasound FMS, Intrepid, Basic |
| Ultrasound FMS, Intrepid, Tipless, 0.9 Ultra |
| Ultrasound FMS, Intrepid, Tipless, 1.1 Ultra |
| Ultrasound FMS, Intrepid, Tipless, 0.9 Nano |
| Ultrasound FMS, Intrepid, Tipless, 1.1 Nano |
| Ultrasound FMS, Intrepid, 30° Kelman, 0.9 mm Mini-Flared ABS, Ultra |
| Ultrasound FMS, Intrepid, 45° Kelman, 0.9 mm Mini-Flared ABS, Ultra |
| Ultrasound FMS, Intrepid, Tipless, 0.9 |
| Ultrasound FMS, Intrepid, 30° Kelman, 0.9 mm Mini Flared ABS, Nano |
| Ultrasound FMS, Intrepid, 45° Kelman, 0.9 mm Mini Flared ABS, Nano |
| Ultrasound FMS, Intrepid, 30° OZil 12, 0.9 mm Mini Flared ABS, Nano |
| Ultrasound FMS, Intrepid, 45° OZil 12, 0.9 mm Mini Flared ABS, Nano |
| Ultrasound FMS, Intrepid, 30° OZil 12, 0.9 mm Mini Flared ABS, Ultra |
| Description |
| Ultrasound FMS, Intrepid, 45° OZil 12, 0.9 mm Mini Flared ABS, Ultra |
| Ultrasound FMS, Intrepid, 30° Kelman, 0.9 mm Mini Flared ABS, 0.9 |
| Ultrasound FMS, Intrepid, 45° Kelman, 0.9 mm Mini Flared ABS, 0.9 |
| Ultrasound FMS, Intrepid, 30° OZil 12, 0.9 mm Mini Flared ABS, 0.9 |
| Ultrasound FMS, Intrepid, 45° OZil 12, 0.9 mm Mini Flared ABS, 0.9 |
| Ultrasound FMS, Intrepid, Basic, J |
| Ultrasound FMS, Intrepid, Tipless, 0.9 Ultra, J |
| Ultrasound FMS, Intrepid, Tipless, 1.1 Ultra, J |
| Ultrasound FMS, Intrepid, Tipless, 0.9 Nano, J |
| Ultrasound FMS, Intrepid, Tipless, 1.1 Nano, J |
| Ultrasound FMS, Intrepid, Tipless, 0.9 J |
| INFI, Multipak, Basic Pak |
| INFI, Multipak, 0.9mm Tipless |
| INFI, Multipak, 1.1mm Tipless |
| INFI MP Procedural Pouch Basic |
| INFI MP Procedural Pouch 0.9mm |
| INFI MP Procedural Pouch 1.1mm |
| Infiniti MP Drain Bags |
| INFI Multi-Pak Basic Stand Alone |
| INFI Multi-Pak 0.9 Tipless Stand Alone |
| INFI Multi-Pak 1.1 Tipless Stand Alone |
| Ultrasound FMS, Intrepid Plus, Basic |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Tipless Ultra |
| Ultrasound FMS, Intrepid Plus, 1.1 MM Tipless Ultra |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Tipless Nano |
| Ultrasound FMS, Intrepid Plus, 1.1 MM Tipless Nano |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30K, Ultra |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45K, Ultra |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Tipless |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30K, Nano |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45K, Nano |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30 OZil, Nano |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45 OZil, Nano |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30 OZil, Ultra |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45 OZil, Ultra |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30K |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45K |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 30 OZil |
| Ultrasound FMS, Intrepid Plus, 0.9 MM Mini-Flared ABS 45 OZil |
{4}------------------------------------------------
·
{5}------------------------------------------------
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
NOV 2 1 2011
Alcon Research, Ltd. c/o Mr. Martin Kaufman, RAC Director, Regulatory Affairs 15800 Alton Parkway Irvine, CA 92816
Re: K112425
Trade/Device Name: Infiniti Vision System (Evergreen II) Regulation Number: 21 CFR 886.4670 Regulation Name: Phacofragmentation system Regulatory Class: II Product Codes: HQC, HQR, MLZ, KYB Dated: August 19, 2011 Received: August 23, 2011
Dear Mr. Kaufman:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{7}------------------------------------------------
CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Kesia Alexander
Malvina B. Evdelman, M.D. Director Division of Ophthalmic, Neurological, and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{8}------------------------------------------------
INDICATIONS FOR USE STATEMENT
510(k) Number (if known): _ k1/2 425
Device Name: Infiniti® Vision System
Indications for Use:
The Infinit® Vision System is indicated for emulsification, separation, and removal of cataracts, the removal of residual cortical material and lens epithelial cells, vitreous aspiration and cutting associated with anterior vitrectomy, bipolar coagulation, and intra-ocular lens injection. The AutoSert™ IOL Injector Handpiece is intended to deliver qualified AcrySof® intraocular lenses into the eye following cataract removal.
The following system modalities additionally support the described indications:
- Ultrasound with UltraChopper Tip achieves the functionality of cataract separation.
- AquaLase achieves the functionality for removal of residual cortical material and lens epithelial cells
- The AutoSert ™ IOL Injector Handpiece achieves the functionality of injection of intraocular lenses. The AutoSert™ is indicated for use with ACRYSOF lenses SN60WF and SN6AD1, as well as approved AcrySof lenses that are specifically indicated for use with this inserter, as indicated in the approved labeling of those lenses.
Prescription Use × AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear. Nose and Throat Devices
510(k) Number f/12425
§ 886.4670 Phacofragmentation system.
(a)
Identification. A phacofragmentation system is an AC-powered device with a fragmenting needle intended for use in cataract surgery to disrupt a cataract with ultrasound and extract the cataract.(b)
Classification. Class II.